Skip to content
Home/Companies/MedTech/Endovascular Engineering

Endovascular Engineering

MedTech·US·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Endovascular Engineering?

Endovascular Engineering is currently owned by 415 Capital Management through 415 Capital Fund II (2024 vintage), since 2025. Across its history, Endovascular Engineering has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-23

415 Capital Management
Most recent investor
415 Capital Management
415 Capital Fund II · 2024 · VC
2 ownership periods · full history below

Key facts

HQUnited States
SectorMedTech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Panakes Partners SGR and 415 Capital Management since 2025.
Co-invest · 2 holders · 2025 · present
Panakes Partners SGR
Panakes Partners SGRActive
2025 · present(1yr) · Panakes Fund Purple · 2021 · Life Sciences VC
415 Capital Management
415 Capital ManagementActive
2025 · present(1yr) · 415 Capital Fund II · 2024 · VC

More from 415 Capital Fund II

Other portfolio companies in the same fund.

CorFlow Therapeutics
CorFlow Therapeutics
Active
MedTechSwitzerland· 2024

More 415 Capital Management portfolio companies

From the same investor, across funds.

Laza Medical
Laza Medical
Active
MedTechUS· 2023
Distalmotion
Active
MedTechSwitzerland· 2022
TRiCares
TRiCares
Active
MedTechGermany· 2022
Cardiac Success
Cardiac Success
Active
MedTechIsrael· 2021
Hilo
Hilo
Active
MedTechSwitzerland· 2021
R3 Vascular
R3 Vascular
Active
MedTechUS· 2020

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Endovascular Engineering

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Endovascular Engineering?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Endovascular Engineering.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue